Endometrial carcinoma stage I: An adjusted algorithm for the approach of treatment strategy

Amiram Bar-Am, Ilan G. Ron, Michael J. Kupferminc, Moshe J. Inbar

Research output: Contribution to journalArticlepeer-review


Standard staging and therapeutic approach to endometrial cancer involves lymph node sampling (LNS) at the time of total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO). Lymphadenectomy prolongs time of surgery and increases the risk of morbidity; where other predictors are available, it may not contribute important supplementary information. 185/247 women with stage I endometrial carcinoma underwent the standard surgery while 62 underwent TAH+BSO. Recurrence and survival were monitored for a mean of 6.5 years and retrospectively reviewed: the rates for groups with and without known lymph node status were alike [13.5% (25/185) recurrence for the former and 12.9% (8/62) for the latter, and 5-year survival rates of 75.7% (140/185) for the former and 74.2 (46/62) for the latter]. Myometrial invasion and histological grade appeared to have been highly accurate predictors without lymph node information. Because information on histological grade is available early and is highly predictive, its use could be incorporated into a revised management algorithm for stage I endometrial cancer which would depend upon ensuring lymphadenectomy for women with low grade histopathology and omitting it for those with high grades on the grounds that no further information is necessary to act appropriately.

Original languageEnglish
Pages (from-to)1055-1058
Number of pages4
JournalOncology Reports
Issue number5
StatePublished - Sep 1997


  • Lymph node sampling
  • Morbidity
  • Stage I endometrial carcinoma
  • Survival
  • Treatment protocol


Dive into the research topics of 'Endometrial carcinoma stage I: An adjusted algorithm for the approach of treatment strategy'. Together they form a unique fingerprint.

Cite this